Drug intelligence / Profile preview

GPN00187

Development stage: Unknown
Lead developer: Beijing Yuanda Jiuhua Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

**GPN00187** is an oral soft-capsule, fixed-dose terpene combination containing eucalyptol, limonene, and alpha-pinene. It is a modified formulation being developed by Beijing Yuanda Jiuhua Pharmaceutical for respiratory diseases, including acute and chronic rhinosinusitis and acute and chronic bronchitis. A Phase I crossover study in healthy Chinese adults evaluates its safety, tolerability, and pharmacokinetics relative to the established eucalyptol/limonene/pinene enteric-capsule formulation marketed as Qinotto. ([synapse.zhihuiya.com](https://synapse.zhihuiya.com/drug/1b887f393d1f47c6b1b56b9960b65e29?campaign_promotion=LS_SEOGW))

Other names: eucalyptol + limonene + alpha-pinene soft capsule桉柠蒎软胶囊

Beyond the preview

Go deeper on GPN00187.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPN00187.

Explore the full profile